Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Estrogen Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT07831499
What this trial is testing

Cyclic vs. Constant Estradiol: Regimens' Effects on Brain Health

Who this might be right for
MenopauseHealthy AdultBrain+1 more
University of Colorado, Denver 40
Testing effectiveness (Phase 2)Study completedNCT02049957
What this trial is testing

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Calithera Biosciences, Inc 118
Large-scale testing (Phase 3)Ended earlyNCT00000419
What this trial is testing

Safety of Estrogens in Lupus: Hormone Replacement Therapy

Who this might be right for
Systemic Lupus Erythematosus
NYU Langone Health 350
Large-scale testing (Phase 3)Study completedNCT00331123
What this trial is testing

Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

Who this might be right for
Hypoactive Sexual Desire Disorder
Warner Chilcott 562
Testing effectiveness (Phase 2)Study completedNCT00375622
What this trial is testing

Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial

Who this might be right for
Hereditary Hemorrhagic Telangiectasia
Rabin Medical Center 60
Testing effectiveness (Phase 2)WithdrawnNCT00370019
What this trial is testing

Effects of an Estrogen Replacement Therapy Skin Patch on Ovulation in Women With Premature Ovarian Failure

Who this might be right for
Premature Ovarian Failure
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not applicableStudy completedNCT04036929
What this trial is testing

Can we Use Estrogen-containing Therapy to Improve Pain in Women After Menopause With Hand Osteoarthritis?

Who this might be right for
Hand Osteoarthritis
University of Oxford 28
Testing effectiveness (Phase 2)Study completedNCT00973102
What this trial is testing

Resuscitative Endocrinology: Single-dose Clinical Uses for Estrogen-Traumatic Hemorrhagic Shock (RESCUE - Shock)

Who this might be right for
Hemorrhagic Shock
University of Texas Southwestern Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT00141570
What this trial is testing

Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women

Who this might be right for
Menopause
Solvay Pharmaceuticals 350
Testing effectiveness (Phase 2)Study completedNCT00290251
What this trial is testing

Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914

Who this might be right for
Leiomyoma
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 72
Post-approval studies (Phase 4)Study completedNCT03418831
What this trial is testing

Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women

Who this might be right for
Schizophrenia
Shanghai Mental Health Center 45
Testing effectiveness (Phase 2)Study completedNCT03628066
What this trial is testing

Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 24
Post-approval studies (Phase 4)UnknownNCT05863975
What this trial is testing

Treatment of HPV Infection in Perimenopausal and Postmenopausal Women

Who this might be right for
HPV Infection
Qianfoshan Hospital 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT06247995
What this trial is testing

A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 20
Large-scale testing (Phase 3)Active Not RecruitingNCT02488967
What this trial is testing

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

Who this might be right for
Breast AdenocarcinomaEstrogen Receptor NegativeHER2/Neu Negative+7 more
NRG Oncology 782
Testing effectiveness (Phase 2)Study completedNCT00152295
What this trial is testing

A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women

Who this might be right for
Postmenopause
Abbott 18
Large-scale testing (Phase 3)Study completedNCT00234819
What this trial is testing

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause

Who this might be right for
Vasomotor Symptoms Associated With Menopause
Wyeth is now a wholly owned subsidiary of Pfizer 325